Literature DB >> 18605769

Pulmonary Langerhans cell histiocytosis and other pulmonary histiocytic diseases: a review.

Timothy Craig Allen1.   

Abstract

CONTEXT: Pulmonary Langerhans cell histiocytosis is the most common and best known pulmonary histiocytic lesion; however, the realm of pulmonary histiocytic lesions also includes an assortment of uncommon diseases that may exhibit pulmonary involvement.
OBJECTIVE: To review pulmonary Langerhans cell histiocytosis and other pulmonary histiocytoses to better ensure correct diagnosis and optimal assessment of prognosis and treatment. DATA SOURCES: Literature review and primary material from the author's institution.
CONCLUSIONS: This review discusses the most common pulmonary histiocytosis, pulmonary Langerhans cell histiocytosis, and also reviews the uncommon pulmonary histiocytic lesions, which are distinct from pulmonary Langerhans cell histiocytosis.

Entities:  

Mesh:

Year:  2008        PMID: 18605769     DOI: 10.5858/2008-132-1171-PLCHAO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis.

Authors:  Arno Dimmler; Helene Geddert; Martin Werner; Gerhard Faller
Journal:  Virchows Arch       Date:  2017-02-20       Impact factor: 4.064

2.  PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.

Authors:  Tian Zhang; Shiva K Das; Diane R Fels; Katherine S Hansen; Terence Z Wong; Mark W Dewhirst; Gordana Vlahovic
Journal:  AJR Am J Roentgenol       Date:  2013-11       Impact factor: 3.959

Review 3.  Diffuse cystic lung diseases.

Authors:  Jay H Ryu; Xinlun Tian; Misbah Baqir; Kaifeng Xu
Journal:  Front Med       Date:  2013-05-11       Impact factor: 4.592

4.  KRASG12D expression in lung-resident myeloid cells promotes pulmonary LCH-like neoplasm sensitive to statin treatment.

Authors:  Tamihiro Kamata; Susan Giblett; Catrin Pritchard
Journal:  Blood       Date:  2017-05-26       Impact factor: 22.113

5.  Lysosomal Disorders Drive Susceptibility to Tuberculosis by Compromising Macrophage Migration.

Authors:  Russell D Berg; Steven Levitte; Mary P O'Sullivan; Seónadh M O'Leary; C J Cambier; James Cameron; Kevin K Takaki; Cecilia B Moens; David M Tobin; Joseph Keane; Lalita Ramakrishnan
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

6.  Multisystemic Pediatric Langerhans cell histiocytosis: a comprehensive clinico-pathological and BRAF V600E mutation study at autopsy.

Authors:  Gargi Kapatia; Prateek Bhatia; Minu Singh; Richa Jain; Deepak Bansal; Kirti Gupta
Journal:  Autops Case Rep       Date:  2020-04-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.